---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-23-000026"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2023-02-28T23:59:59+00:00"
generated_at: "2026-06-18T22:15:23.309125+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst Q4 revenue $69.2M (+7% YoY); Adjusted EBITDA loss narrows; board adds Matthew Kolb

## Summary
- Q4 total revenue $69.2M (+7% YoY); full-year revenue $276.2M (+14% YoY).
- GAAP net loss Q4 $35.8M vs $49.0M loss a year ago; full-year net loss $137.4M vs $153.2M.
- Adjusted EBITDA Q4 -$0.6M (improved 90% from -$6.3M); full-year -$2.5M (improved 78% from -$11.2M).
- Matthew Kolb (EVP/COO Carle Health) to join board effective July 1, 2023; Carle Health made open-market stock purchase.
- CEO Dan Burton purchased shares on open market, estimates he is among top 20 shareholders.

## SEC filing metadata
- accession: 0001636422-23-000026
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2023-02-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000026/0001636422-23-000026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000026/hcat-20230228.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-23-000026
- JSON: https://secwatch.observer/filing/0001636422-23-000026.json
- Plain text: https://secwatch.observer/filing/0001636422-23-000026.txt

## Key facts
- Earnings Releases
  Health Catalyst, Inc. reported Three Months Ended December 31, 2022 results: revenue $ 69,162, net income $ (35,782).
  - Period: Three Months Ended December 31, 2022
  - Revenue: $ 69,162
  - Net income: $ (35,782)
  - Result: reported results
  source text: Financial Highlights for the Three and Twelve Months Ended December 31, 2022 Key Financial Metrics Three Months Ended December 31, Year over Year Change Twelve Months Ended December 31, Year over Year Change 2022 2021 2022 2021 GAAP Financial Data: (in thousands, except percentages) (in thousands, except percentages) Technology revenue $ 44,664 $ 40,088 11% $ 176,288 $ 147,718 19% Professional services revenue $ 24,498 $ 24,628 (1)% $ 99,948 $ 94,208 6% Total revenue $ 69,162 $ 64,716 7% $ 276,236 $ 241,926 14% Loss from operations $ (36,745) $ (44,765) 18% $ (140,005) $ (143,650) 3% Net loss $ (35,782) $ (48,992) 27% $ (137,403) $ (153,210) 10%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000026/0001636422-23-000026-index.htm
- Earnings Releases
  Health Catalyst, Inc. reported Twelve Months Ended December 31, 2022 results: revenue $ 276,236, net income $ (137,403).
  - Period: Twelve Months Ended December 31, 2022
  - Revenue: $ 276,236
  - Net income: $ (137,403)
  - Result: reported results
  source text: Financial Highlights for the Three and Twelve Months Ended December 31, 2022 Key Financial Metrics Three Months Ended December 31, Year over Year Change Twelve Months Ended December 31, Year over Year Change 2022 2021 2022 2021 GAAP Financial Data: (in thousands, except percentages) (in thousands, except percentages) Technology revenue $ 44,664 $ 40,088 11% $ 176,288 $ 147,718 19% Professional services revenue $ 24,498 $ 24,628 (1)% $ 99,948 $ 94,208 6% Total revenue $ 69,162 $ 64,716 7% $ 276,236 $ 241,926 14% Loss from operations $ (36,745) $ (44,765) 18% $ (140,005) $ (143,650) 3% Net loss $ (35,782) $ (48,992) 27% $ (137,403) $ (153,210) 10%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000026/0001636422-23-000026-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.